Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.

Postgraduate medicine

Volumn 125, Issue 5, 2013, Pages 130-138

  Gibofsky, Allan ^a   Silberstein, Stephen ^b   Argoff, Charles ^b   Daniels, Stephen ^b   Jensen, Steve ^b   Young, Clarence L ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE PAIN; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HALLUX VALGUS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PAIN, POSTOPERATIVE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ACUTE PAIN; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; HALLUX VALGUS; HUMANS; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; YOUNG ADULT;

EID: 84887835349     PISSN: None     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2013.09.2693     Document Type: Article

References (0)